The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer

RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma

(2017) Weilin Zhao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The role of stromal cancer-associated fibroblasts in pancreatic cancer

(2017) Dagny von Ahrens et al.   Journal of Hematology & Oncology

Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes

(2017) Katharina Burmeister et al.   PLoS One

Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate

(2017) Ran Tao et al.   Experimental and Therapeutic Medicine

Pancreatic cancer

(2016) Terumi Kamisawa et al.   LANCET

Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib

(2015) WEN-JIE WANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells

(2015) Yehua Shen et al.   TUMOR BIOLOGY

PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradation of β-catenin

(2014) MENG-YAO WU et al.   ONCOLOGY REPORTS

Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway

(2014) XIN XIE et al.   Oncology Letters

GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways

(2013) Konstantinos N. Aronis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin

(2013) LIU-MEI SHOU et al.   ONCOLOGY REPORTS

Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells

(2012) Jae-Won Kim et al.   CANCER BIOLOGY & THERAPY

TGF-β1 enhances tumor-induced angiogenesis via JNK pathway and macrophage infiltration in an improved zebrafish embryo/xenograft glioma model

(2012) Xiao-jun Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Ginsenoside Rg3 Inhibits Endothelial Progenitor Cell Differentiation through Attenuation of VEGF-Dependent Akt/eNOS Signaling

(2012) Jae-Won Kim et al.   PHYTOTHERAPY RESEARCH

PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKα and sustained activation of the NF-κB pathway

(2011) Wei Li et al.   CANCER LETTERS

Gensenoside Rg3 Inhibits Hypoxia-induced VEGF Expression in Human Cancer Cells

(2011) Qing-Jiang Chen et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway

(2011) Wei Li et al.   EUROPEAN JOURNAL OF CANCER

Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis

(2010) Wei Li et al.   CANCER SCIENCE

The angiogenic switch in carcinogenesis

(2009) Vanessa Baeriswyl et al.   SEMINARS IN CANCER BIOLOGY